AVITA Medical (AVHHL) Capital Expenditures (2019 - 2025)

AVITA Medical (AVHHL) has reported Capital Expenditures for 7 consecutive years, with -$674000.0 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Capital Expenditures fell 141.81% year-over-year to -$674000.0; the trailing twelve-month figure through Dec 2025 stood at $1.0 million (down 89.04% YoY), and the FY2025 full-year result was $1.0 million, down 89.04% from the prior year.
• Capital Expenditures eased to -$674000.0 in Q4 2025 per AVHHL's latest filing, from $934000.0 in the prior quarter.
• Across five years, Capital Expenditures topped out at $3.8 million in Q3 2024 and bottomed at -$686000.0 in Q4 2022.
• Historically, Capital Expenditures has averaged $776764.7 across 5 years, with a median of $528000.0 in 2021.
• The sharpest annual moves came in 2024 and 2025: Capital Expenditures jumped 786.96% in 2024, then plunged 141.81% in 2025.
• Over 5 years, Capital Expenditures stood at $763000.0 in 2021, then tumbled by 189.91% to -$686000.0 in 2022, then surged by 143.15% to $296000.0 in 2023, then soared by 444.59% to $1.6 million in 2024, then slumped by 141.81% to -$674000.0 in 2025.
• According to Business Quant data, Capital Expenditures over the past three periods registered -$674000.0, $934000.0, and $1.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.